Massmutual Trust CO Fsb Kura Oncology, Inc. Transaction History
Massmutual Trust CO Fsb
- $3.48 Billion
- Q3 2024
A detailed history of Massmutual Trust CO Fsb transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Massmutual Trust CO Fsb holds 19 shares of KURA stock, worth $338. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 19
-0.0%
Holding current value
$338
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KURA
# of Institutions
184Shares Held
79.6MCall Options Held
148KPut Options Held
63K-
Suvretta Capital Management, LLC New York, NY7.07MShares$126 Million6.08% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$124 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.81MShares$104 Million4.23% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY5.41MShares$96.5 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY4.54MShares$81 Million3.78% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $1.19B
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...